nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—SLC22A7—Fluorouracil—head and neck cancer	0.359	0.505	CbGbCtD
Oxtriphylline—SLC22A7—Docetaxel—head and neck cancer	0.274	0.386	CbGbCtD
Oxtriphylline—CYP1A2—Fluorouracil—head and neck cancer	0.0778	0.109	CbGbCtD
Oxtriphylline—HDAC2—parathyroid gland—head and neck cancer	0.0125	0.104	CbGeAlD
Oxtriphylline—Caffeine—PIK3CA—head and neck cancer	0.0117	0.693	CrCbGaD
Oxtriphylline—PDE4C—tongue—head and neck cancer	0.0107	0.0881	CbGeAlD
Oxtriphylline—PDE4C—mouth—head and neck cancer	0.00717	0.0593	CbGeAlD
Oxtriphylline—HDAC2—tongue—head and neck cancer	0.00661	0.0547	CbGeAlD
Oxtriphylline—HDAC2—exocrine gland—head and neck cancer	0.00595	0.0492	CbGeAlD
Oxtriphylline—HDAC2—hair follicle—head and neck cancer	0.00567	0.0468	CbGeAlD
Oxtriphylline—PDE3B—connective tissue—head and neck cancer	0.00463	0.0383	CbGeAlD
Oxtriphylline—HDAC2—mouth—head and neck cancer	0.00445	0.0368	CbGeAlD
Oxtriphylline—HDAC2—neck—head and neck cancer	0.0038	0.0314	CbGeAlD
Oxtriphylline—ADORA2B—trachea—head and neck cancer	0.00322	0.0266	CbGeAlD
Oxtriphylline—ADORA1—saliva-secreting gland—head and neck cancer	0.003	0.0248	CbGeAlD
Oxtriphylline—HDAC2—saliva-secreting gland—head and neck cancer	0.00297	0.0245	CbGeAlD
Oxtriphylline—HDAC2—connective tissue—head and neck cancer	0.00272	0.0225	CbGeAlD
Oxtriphylline—Theophylline—CYP1A1—head and neck cancer	0.00261	0.155	CrCbGaD
Oxtriphylline—PDE4C—head—head and neck cancer	0.00259	0.0214	CbGeAlD
Oxtriphylline—HDAC2—epithelium—head and neck cancer	0.00259	0.0214	CbGeAlD
Oxtriphylline—PDE4D—thyroid gland—head and neck cancer	0.00257	0.0212	CbGeAlD
Oxtriphylline—Caffeine—CYP1A1—head and neck cancer	0.00256	0.152	CrCbGaD
Oxtriphylline—ADORA2A—lymphoid tissue—head and neck cancer	0.00234	0.0193	CbGeAlD
Oxtriphylline—PDE4B—parotid gland—head and neck cancer	0.00232	0.0192	CbGeAlD
Oxtriphylline—PDE4A—thyroid gland—head and neck cancer	0.00227	0.0188	CbGeAlD
Oxtriphylline—ADORA2B—head—head and neck cancer	0.00226	0.0187	CbGeAlD
Oxtriphylline—PDE4B—saliva-secreting gland—head and neck cancer	0.00222	0.0184	CbGeAlD
Oxtriphylline—HDAC2—lymphoid tissue—head and neck cancer	0.00199	0.0165	CbGeAlD
Oxtriphylline—PDE3B—lymph node—head and neck cancer	0.00191	0.0158	CbGeAlD
Oxtriphylline—ADORA2A—head—head and neck cancer	0.00188	0.0156	CbGeAlD
Oxtriphylline—PDE3A—thyroid gland—head and neck cancer	0.00188	0.0155	CbGeAlD
Oxtriphylline—ADORA1—thyroid gland—head and neck cancer	0.00183	0.0151	CbGeAlD
Oxtriphylline—HDAC2—thyroid gland—head and neck cancer	0.00181	0.015	CbGeAlD
Oxtriphylline—PDE4B—trachea—head and neck cancer	0.00171	0.0142	CbGeAlD
Oxtriphylline—ADORA1—head—head and neck cancer	0.00163	0.0134	CbGeAlD
Oxtriphylline—HDAC2—head—head and neck cancer	0.00161	0.0133	CbGeAlD
Oxtriphylline—PDE4D—lymph node—head and neck cancer	0.0016	0.0132	CbGeAlD
Oxtriphylline—PDE4B—lymphoid tissue—head and neck cancer	0.00149	0.0123	CbGeAlD
Oxtriphylline—PDE4A—lymph node—head and neck cancer	0.00141	0.0117	CbGeAlD
Oxtriphylline—PDE4B—thyroid gland—head and neck cancer	0.00136	0.0112	CbGeAlD
Oxtriphylline—PDE4B—head—head and neck cancer	0.0012	0.00994	CbGeAlD
Oxtriphylline—PDE3A—lymph node—head and neck cancer	0.00117	0.00965	CbGeAlD
Oxtriphylline—ADORA1—lymph node—head and neck cancer	0.00114	0.00941	CbGeAlD
Oxtriphylline—HDAC2—lymph node—head and neck cancer	0.00112	0.00929	CbGeAlD
Oxtriphylline—PDE4B—lymph node—head and neck cancer	0.000842	0.00696	CbGeAlD
Oxtriphylline—CYP1A2—thyroid gland—head and neck cancer	0.000832	0.00688	CbGeAlD
Oxtriphylline—PDE3B—Signaling by GPCR—IL2—head and neck cancer	9.05e-05	0.0006	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—IL2—head and neck cancer	8.91e-05	0.00059	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—HRAS—head and neck cancer	8.82e-05	0.000584	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—MAPK1—head and neck cancer	8.79e-05	0.000582	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—NOTCH1—head and neck cancer	8.78e-05	0.000582	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—IL2—head and neck cancer	8.74e-05	0.000579	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—NOTCH1—head and neck cancer	8.7e-05	0.000577	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.7e-05	0.000576	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—IL2—head and neck cancer	8.64e-05	0.000572	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—AKT1—head and neck cancer	8.55e-05	0.000567	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—IL2—head and neck cancer	8.48e-05	0.000561	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—IL2—head and neck cancer	8.25e-05	0.000546	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—MAPK3—head and neck cancer	8.22e-05	0.000545	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NOTCH1—head and neck cancer	8.08e-05	0.000535	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NOTCH1—head and neck cancer	8.01e-05	0.000531	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—IL2—head and neck cancer	7.94e-05	0.000526	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—IL2—head and neck cancer	7.84e-05	0.00052	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—MAPK1—head and neck cancer	7.83e-05	0.000518	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—EGFR—head and neck cancer	7.82e-05	0.000518	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—AKT1—head and neck cancer	7.79e-05	0.000516	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NOTCH1—head and neck cancer	7.77e-05	0.000515	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NOTCH1—head and neck cancer	7.64e-05	0.000506	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—PIK3CA—head and neck cancer	7.62e-05	0.000505	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—MAPK3—head and neck cancer	7.5e-05	0.000497	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—PIK3CA—head and neck cancer	7.48e-05	0.000495	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—TP53—head and neck cancer	7.38e-05	0.000489	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—MAPK3—head and neck cancer	7.28e-05	0.000482	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NOTCH1—head and neck cancer	7.28e-05	0.000482	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—MAPK3—head and neck cancer	7.16e-05	0.000474	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—MAPK1—head and neck cancer	7.14e-05	0.000473	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—EGFR—head and neck cancer	7.14e-05	0.000473	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NOTCH1—head and neck cancer	7.08e-05	0.000469	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—HRAS—head and neck cancer	7.05e-05	0.000467	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—MAPK1—head and neck cancer	6.93e-05	0.000459	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—EGFR—head and neck cancer	6.92e-05	0.000459	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—PIK3CA—head and neck cancer	6.82e-05	0.000452	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—MAPK3—head and neck cancer	6.81e-05	0.000451	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NOTCH1—head and neck cancer	6.81e-05	0.000451	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—MAPK1—head and neck cancer	6.81e-05	0.000451	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—EGFR—head and neck cancer	6.81e-05	0.000451	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—PIK3CA—head and neck cancer	6.79e-05	0.00045	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—IL2—head and neck cancer	6.75e-05	0.000447	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NOTCH1—head and neck cancer	6.73e-05	0.000446	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—MAPK3—head and neck cancer	6.63e-05	0.000439	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—PIK3CA—head and neck cancer	6.62e-05	0.000438	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—PIK3CA—head and neck cancer	6.51e-05	0.000431	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—MAPK1—head and neck cancer	6.48e-05	0.00043	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—EGFR—head and neck cancer	6.48e-05	0.000429	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—MAPK3—head and neck cancer	6.38e-05	0.000423	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—MAPK1—head and neck cancer	6.31e-05	0.000418	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—EGFR—head and neck cancer	6.31e-05	0.000418	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—MAPK3—head and neck cancer	6.31e-05	0.000418	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—HRAS—head and neck cancer	6.28e-05	0.000416	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—AKT1—head and neck cancer	6.23e-05	0.000413	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—PIK3CA—head and neck cancer	6.2e-05	0.00041	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—PIK3CA—head and neck cancer	6.2e-05	0.00041	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—IL2—head and neck cancer	6.13e-05	0.000406	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—AKT1—head and neck cancer	6.11e-05	0.000405	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—MAPK1—head and neck cancer	6.07e-05	0.000402	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—EGFR—head and neck cancer	6.07e-05	0.000402	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IL2—head and neck cancer	6.04e-05	0.0004	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—PIK3CA—head and neck cancer	6.03e-05	0.000399	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—PIK3CA—head and neck cancer	6.01e-05	0.000398	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTGS2—head and neck cancer	6e-05	0.000397	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—MAPK1—head and neck cancer	6e-05	0.000397	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—EGFR—head and neck cancer	6e-05	0.000397	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—PIK3CA—head and neck cancer	5.91e-05	0.000392	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CCND1—head and neck cancer	5.89e-05	0.00039	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—PIK3CA—head and neck cancer	5.8e-05	0.000384	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—PIK3CA—head and neck cancer	5.73e-05	0.00038	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—HRAS—head and neck cancer	5.73e-05	0.00038	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—PTEN—head and neck cancer	5.69e-05	0.000377	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NOTCH1—head and neck cancer	5.66e-05	0.000375	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—PIK3CA—head and neck cancer	5.63e-05	0.000373	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—AKT1—head and neck cancer	5.57e-05	0.000369	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—HRAS—head and neck cancer	5.56e-05	0.000368	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—AKT1—head and neck cancer	5.55e-05	0.000367	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL2—head and neck cancer	5.51e-05	0.000365	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—PIK3CA—head and neck cancer	5.47e-05	0.000363	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—HRAS—head and neck cancer	5.47e-05	0.000362	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—AKT1—head and neck cancer	5.41e-05	0.000358	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCND1—head and neck cancer	5.38e-05	0.000356	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL2—head and neck cancer	5.35e-05	0.000354	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—AKT1—head and neck cancer	5.32e-05	0.000352	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—PIK3CA—head and neck cancer	5.27e-05	0.000349	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NOTCH1—head and neck cancer	5.26e-05	0.000348	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL2—head and neck cancer	5.26e-05	0.000348	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTEN—head and neck cancer	5.23e-05	0.000347	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCND1—head and neck cancer	5.21e-05	0.000345	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—PIK3CA—head and neck cancer	5.21e-05	0.000345	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—HRAS—head and neck cancer	5.21e-05	0.000345	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PTEN—head and neck cancer	5.19e-05	0.000344	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—VEGFA—head and neck cancer	5.14e-05	0.00034	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCND1—head and neck cancer	5.13e-05	0.00034	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—STAT3—head and neck cancer	5.09e-05	0.000337	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—HRAS—head and neck cancer	5.06e-05	0.000335	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—AKT1—head and neck cancer	5.06e-05	0.000335	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—AKT1—head and neck cancer	5.06e-05	0.000335	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PTEN—head and neck cancer	5.03e-05	0.000333	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL2—head and neck cancer	5.01e-05	0.000332	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PTEN—head and neck cancer	4.95e-05	0.000328	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.94e-05	0.000328	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—MAPK3—head and neck cancer	4.93e-05	0.000326	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—AKT1—head and neck cancer	4.92e-05	0.000326	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—AKT1—head and neck cancer	4.91e-05	0.000325	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.89e-05	0.000324	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCND1—head and neck cancer	4.88e-05	0.000323	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—HRAS—head and neck cancer	4.87e-05	0.000323	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL2—head and neck cancer	4.87e-05	0.000323	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MAPK3—head and neck cancer	4.86e-05	0.000322	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—AKT1—head and neck cancer	4.83e-05	0.00032	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—HRAS—head and neck cancer	4.82e-05	0.000319	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—MAPK3—head and neck cancer	4.81e-05	0.000319	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCND1—head and neck cancer	4.75e-05	0.000315	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—AKT1—head and neck cancer	4.74e-05	0.000314	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PTEN—head and neck cancer	4.71e-05	0.000312	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL2—head and neck cancer	4.69e-05	0.000311	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—MAPK1—head and neck cancer	4.69e-05	0.000311	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—EGFR—head and neck cancer	4.69e-05	0.00031	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VEGFA—head and neck cancer	4.69e-05	0.00031	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—AKT1—head and neck cancer	4.68e-05	0.00031	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—STAT3—head and neck cancer	4.68e-05	0.00031	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NAT2—head and neck cancer	4.66e-05	0.000308	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—STAT3—head and neck cancer	4.64e-05	0.000307	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL2—head and neck cancer	4.63e-05	0.000307	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MAPK1—head and neck cancer	4.62e-05	0.000306	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—EGFR—head and neck cancer	4.62e-05	0.000306	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—AKT1—head and neck cancer	4.6e-05	0.000304	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PTEN—head and neck cancer	4.58e-05	0.000304	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCND1—head and neck cancer	4.57e-05	0.000303	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VEGFA—head and neck cancer	4.55e-05	0.000301	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCND1—head and neck cancer	4.52e-05	0.000299	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—STAT3—head and neck cancer	4.5e-05	0.000298	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	4.48e-05	0.000297	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—AKT1—head and neck cancer	4.47e-05	0.000296	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VEGFA—head and neck cancer	4.47e-05	0.000296	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—MAPK3—head and neck cancer	4.47e-05	0.000296	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MAPK3—head and neck cancer	4.43e-05	0.000294	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—STAT3—head and neck cancer	4.43e-05	0.000293	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PTEN—head and neck cancer	4.41e-05	0.000292	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PTEN—head and neck cancer	4.36e-05	0.000289	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—AKT1—head and neck cancer	4.3e-05	0.000285	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MAPK3—head and neck cancer	4.3e-05	0.000285	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VEGFA—head and neck cancer	4.26e-05	0.000282	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—MAPK1—head and neck cancer	4.25e-05	0.000282	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—EGFR—head and neck cancer	4.25e-05	0.000282	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—AKT1—head and neck cancer	4.25e-05	0.000282	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MAPK3—head and neck cancer	4.23e-05	0.00028	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MAPK1—head and neck cancer	4.22e-05	0.000279	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—EGFR—head and neck cancer	4.22e-05	0.000279	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—STAT3—head and neck cancer	4.21e-05	0.000279	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VEGFA—head and neck cancer	4.14e-05	0.000274	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—STAT3—head and neck cancer	4.1e-05	0.000272	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MAPK1—head and neck cancer	4.09e-05	0.000271	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—EGFR—head and neck cancer	4.09e-05	0.000271	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—DPYD—head and neck cancer	4.08e-05	0.00027	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—PIK3CA—head and neck cancer	4.07e-05	0.000269	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MAPK3—head and neck cancer	4.03e-05	0.000267	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MAPK1—head and neck cancer	4.02e-05	0.000267	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—EGFR—head and neck cancer	4.02e-05	0.000267	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—PIK3CA—head and neck cancer	4.01e-05	0.000266	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VEGFA—head and neck cancer	3.98e-05	0.000264	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—STAT3—head and neck cancer	3.95e-05	0.000261	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VEGFA—head and neck cancer	3.94e-05	0.000261	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MAPK3—head and neck cancer	3.92e-05	0.000259	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—STAT3—head and neck cancer	3.9e-05	0.000258	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL2—head and neck cancer	3.89e-05	0.000258	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TP53—head and neck cancer	3.88e-05	0.000257	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—YAP1—head and neck cancer	3.87e-05	0.000257	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MAPK1—head and neck cancer	3.83e-05	0.000254	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—EGFR—head and neck cancer	3.83e-05	0.000254	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCND1—head and neck cancer	3.8e-05	0.000251	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MAPK3—head and neck cancer	3.77e-05	0.00025	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—HRAS—head and neck cancer	3.76e-05	0.000249	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MAPK1—head and neck cancer	3.73e-05	0.000247	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—EGFR—head and neck cancer	3.73e-05	0.000247	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MAPK3—head and neck cancer	3.72e-05	0.000247	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—HRAS—head and neck cancer	3.71e-05	0.000246	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PIK3CA—head and neck cancer	3.69e-05	0.000245	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PTEN—head and neck cancer	3.66e-05	0.000243	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PIK3CA—head and neck cancer	3.66e-05	0.000242	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—AKT1—head and neck cancer	3.66e-05	0.000242	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL2—head and neck cancer	3.62e-05	0.00024	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MAPK1—head and neck cancer	3.59e-05	0.000238	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—EGFR—head and neck cancer	3.59e-05	0.000238	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PIK3CA—head and neck cancer	3.55e-05	0.000235	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MAPK1—head and neck cancer	3.54e-05	0.000235	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—EGFR—head and neck cancer	3.54e-05	0.000235	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TP53—head and neck cancer	3.54e-05	0.000235	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCND1—head and neck cancer	3.53e-05	0.000234	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PIK3CA—head and neck cancer	3.49e-05	0.000231	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TP53—head and neck cancer	3.43e-05	0.000227	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—HRAS—head and neck cancer	3.41e-05	0.000226	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PTEN—head and neck cancer	3.41e-05	0.000226	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—HRAS—head and neck cancer	3.39e-05	0.000224	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TP53—head and neck cancer	3.38e-05	0.000224	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PIK3CA—head and neck cancer	3.32e-05	0.00022	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—AKT1—head and neck cancer	3.32e-05	0.00022	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VEGFA—head and neck cancer	3.31e-05	0.000219	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—HRAS—head and neck cancer	3.28e-05	0.000218	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—STAT3—head and neck cancer	3.28e-05	0.000217	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—AKT1—head and neck cancer	3.28e-05	0.000217	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—AKT1—head and neck cancer	3.25e-05	0.000215	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PIK3CA—head and neck cancer	3.23e-05	0.000214	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—HRAS—head and neck cancer	3.23e-05	0.000214	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TP53—head and neck cancer	3.22e-05	0.000213	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MAPK3—head and neck cancer	3.13e-05	0.000207	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TP53—head and neck cancer	3.13e-05	0.000207	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PIK3CA—head and neck cancer	3.11e-05	0.000206	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VEGFA—head and neck cancer	3.08e-05	0.000204	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PIK3CA—head and neck cancer	3.08e-05	0.000204	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—HRAS—head and neck cancer	3.08e-05	0.000204	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—STAT3—head and neck cancer	3.05e-05	0.000202	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—AKT1—head and neck cancer	3.02e-05	0.0002	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TP53—head and neck cancer	3.01e-05	0.000199	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—HRAS—head and neck cancer	2.99e-05	0.000198	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—AKT1—head and neck cancer	2.99e-05	0.000198	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MAPK1—head and neck cancer	2.98e-05	0.000197	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—EGFR—head and neck cancer	2.98e-05	0.000197	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TP53—head and neck cancer	2.98e-05	0.000197	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.91e-05	0.000193	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MAPK3—head and neck cancer	2.91e-05	0.000193	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—AKT1—head and neck cancer	2.9e-05	0.000192	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—HRAS—head and neck cancer	2.88e-05	0.000191	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—AKT1—head and neck cancer	2.85e-05	0.000189	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—HRAS—head and neck cancer	2.85e-05	0.000188	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MAPK1—head and neck cancer	2.77e-05	0.000183	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—EGFR—head and neck cancer	2.77e-05	0.000183	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—AKT1—head and neck cancer	2.72e-05	0.00018	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—AKT1—head and neck cancer	2.64e-05	0.000175	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PIK3CA—head and neck cancer	2.58e-05	0.000171	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—AKT1—head and neck cancer	2.54e-05	0.000168	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.54e-05	0.000168	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—AKT1—head and neck cancer	2.51e-05	0.000166	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TP53—head and neck cancer	2.5e-05	0.000166	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PIK3CA—head and neck cancer	2.4e-05	0.000159	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—HRAS—head and neck cancer	2.39e-05	0.000158	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—TYMS—head and neck cancer	2.33e-05	0.000154	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TP53—head and neck cancer	2.32e-05	0.000154	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.3e-05	0.000152	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HRAS—head and neck cancer	2.22e-05	0.000147	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GPX1—head and neck cancer	2.2e-05	0.000146	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.18e-05	0.000144	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AKT1—head and neck cancer	2.11e-05	0.00014	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AKT1—head and neck cancer	1.96e-05	0.00013	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.79e-05	0.000119	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.3e-05	8.59e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTEN—head and neck cancer	1.13e-05	7.49e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PIK3CA—head and neck cancer	7.98e-06	5.28e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AKT1—head and neck cancer	6.52e-06	4.32e-05	CbGpPWpGaD
